Qinhao Wang

539 total citations
22 papers, 370 citations indexed

About

Qinhao Wang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Qinhao Wang has authored 22 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Qinhao Wang's work include Ubiquitin and proteasome pathways (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and VLSI and Analog Circuit Testing (3 papers). Qinhao Wang is often cited by papers focused on Ubiquitin and proteasome pathways (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and VLSI and Analog Circuit Testing (3 papers). Qinhao Wang collaborates with scholars based in China, Japan and United States. Qinhao Wang's co-authors include Yi Ru, Libo Yao, Guang Yan, Xia Li, Mei Zhang, Hua Han, Guodong Zhu, Tao Pan, Lan Shen and Jing Zhang and has published in prestigious journals such as Oncogene, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Qinhao Wang

21 papers receiving 364 citations

Peers

Qinhao Wang

ONCOL

Seung-Hyun Oh South Korea

Yuting Dong China

Xiaobing Jiang China

Russell Moser United States

Zhongmin Wang China

Hirokazu Sugino Japan

Jennifer Cruickshank Canada

Youlim Son South Korea

Shuwen Shen China

Dongbin Bi China

Seung-Hyun Oh South Korea

Qinhao Wang

309 ×1.4

71 ×0.9

81 ×1.1

ONCOL

13 ×0.2

29 ×0.5

Citations per year, relative to Qinhao Wang Qinhao Wang (= 1×) peers Seung-Hyun Oh

Countries citing papers authored by Qinhao Wang

Since Specialization

Citations

This map shows the geographic impact of Qinhao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinhao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinhao Wang more than expected).

Fields of papers citing papers by Qinhao Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qinhao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinhao Wang. The network helps show where Qinhao Wang may publish in the future.

Co-authorship network of co-authors of Qinhao Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Qinhao Wang. A scholar is included among the top collaborators of Qinhao Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qinhao Wang. Qinhao Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Meng, Xiaopeng Jia, Fei Li, et al.. (2025). Injectable microenvironment-responsive hydrogels encapsulating engineered NF-κB-targeting circular RNA for osteoarthritis therapy. Journal of Controlled Release. 385. 114039–114039. 2 indexed citations

Wang, Qinhao, Yuanyuan Su, Ruiqi Sun, et al.. (2024). MIIP downregulation drives colorectal cancer progression through inducing peri-cancerous adipose tissue browning. Cell & Bioscience. 14(1). 12–12. 6 indexed citations

Su, Yuanyuan, Qinhao Wang, Yi Ru, et al.. (2022). [Regulation of PD-L1 posttranslational modification and its application progress in tumor immunotherapy].. PubMed. 38(11). 1036–1043. 1 indexed citations

Wang, Qinhao, Yi Ru, Wei Hu, et al.. (2021). MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis. Cancer Biology and Medicine. 19(6). 1–18. 6 indexed citations

Li, Bingqing, et al.. (2021). miR-145-5p Modulates Gefitinib Resistance by Targeting NRAS and MEST in Non-Small Cell Lung Cancer.. PubMed. 51(5). 625–637. 14 indexed citations

Chen, Qiusong, et al.. (2021). The Impact of Contact Position on the Retention Performance in Thin‐Film Ferroelectric Transistors. physica status solidi (a). 218(22). 1 indexed citations

Lin, Dong, et al.. (2021). A Multifunctional Flexible Ferroelectric Transistor Sensor for Electronic Skin. Advanced Materials Interfaces. 8(24). 17 indexed citations

Wang, Qinhao, et al.. (2020). VDF-content-guided selection of piezoelectric P(VDF-TrFE) films in sensing and energy harvesting applications. Energy Conversion and Management. 211. 112771–112771. 47 indexed citations

Hu, Wei, Yi Ru, Guang Yan, et al.. (2020). MIIP inhibits EMT and cell invasion in prostate cancer through miR-181a/b-5p-KLF17 axis.. PubMed. 10(2). 630–647. 22 indexed citations

10.

Yan, Guang, Yi Ru, Xin Xiong, et al.. (2019). MIIP inhibits the growth of prostate cancer via interaction with PP1α and negative modulation of AKT signaling. Cell Communication and Signaling. 17(1). 44–44. 13 indexed citations

11.

Zhang, Yao, Qi Li, Qinhao Wang, et al.. (2019). IDH2 compensates for IDH1 mutation to maintain cell survival under hypoxic conditions in IDH1‑mutant tumor cells. Molecular Medicine Reports. 20(2). 1893–1900. 4 indexed citations

12.

Wang, Qinhao, et al.. (2019). High-Level Engineering Change Through Programmable Datapath and SMT Solvers. 26. 1–5. 2 indexed citations

13.

Shen, Liangliang, Xuan Qu, Huichen Li, et al.. (2018). NDRG2 facilitates colorectal cancer differentiation through the regulation of Skp2-p21/p27 axis. Oncogene. 37(13). 1759–1774. 56 indexed citations

14.

Pan, Tao, Mei Zhang, Fang Zhang, et al.. (2017). NDRG2 overexpression suppresses hepatoma cells survival during metabolic stress through disturbing the activation of fatty acid oxidation. Biochemical and Biophysical Research Communications. 483(2). 860–866. 16 indexed citations

15.

Yan, Guang, Yi Ru, Kerong Wu, et al.. (2017). GOLM1 promotes prostate cancer progression through activating PI3K‐AKT‐mTOR signaling. The Prostate. 78(3). 166–177. 61 indexed citations

16.

Fujita, Masahiro, et al.. (2017). Template based synthesis for high performance computing. 1–6. 3 indexed citations

17.

Li, Xia, Nan Li, Rui Zhang, et al.. (2017). Immunoproapoptotic molecule scFv-Fdt-tBid modified mesenchymal stem cells for prostate cancer dual-targeted therapy. Cancer Letters. 402. 32–42. 12 indexed citations

18.

Ru, Yi, Qinhao Wang, Xiping Liu, et al.. (2016). The chimeric ubiquitin ligase SH2-U-box inhibits the growth of imatinib-sensitive and resistant CML by targeting the native and T315I-mutant BCR-ABL. Scientific Reports. 6(1). 28352–28352. 20 indexed citations

19.

Wang, Qinhao, et al.. (2016). Automatically adjusting system level designs after RTL/gate-level ECO. 22. 108–112. 2 indexed citations

20.

Zhong, Daixing, Yi Ru, Qinhao Wang, et al.. (2015). Chimeric ubiquitin ligases inhibit non-small cell lung cancer via negative modulation of EGFR signaling. Cancer Letters. 359(1). 57–64. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact